In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide. Li T, Fang J, Chu J, Liu X, et al. J Cancer Res Clin Oncol 2022;148:1073-1085.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li T, Fang J, Chu J, Liu X, et al. In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide. J Cancer Res Clin Oncol 2022;148:1073-1085.
PMID: 35038020